nodes	percent_of_prediction	percent_of_DWPC	metapath
Dimetindene—Dimetacrine—ACHE—prostate cancer	0.0346	0.122	CrCbGaD
Dimetindene—Disopyramide—SLC22A1—prostate cancer	0.0171	0.0604	CrCbGaD
Dimetindene—Chlorphenamine—SLC22A1—prostate cancer	0.0125	0.0441	CrCbGaD
Dimetindene—Diphenhydramine—CYP2C18—prostate cancer	0.0104	0.0366	CrCbGaD
Dimetindene—Clomipramine—GSTP1—prostate cancer	0.0101	0.0358	CrCbGaD
Dimetindene—Chlorphenamine—CYP3A5—prostate cancer	0.0101	0.0356	CrCbGaD
Dimetindene—Imipramine—SLC22A3—prostate cancer	0.00892	0.0315	CrCbGaD
Dimetindene—Diphenhydramine—SLC22A1—prostate cancer	0.00847	0.0299	CrCbGaD
Dimetindene—Carbinoxamine—CYP2E1—prostate cancer	0.00814	0.0287	CrCbGaD
Dimetindene—Carbinoxamine—CYP2C19—prostate cancer	0.00806	0.0285	CrCbGaD
Dimetindene—Imipramine—CYP2C18—prostate cancer	0.00784	0.0277	CrCbGaD
Dimetindene—Olopatadine—CYP3A4—prostate cancer	0.00742	0.0262	CrCbGaD
Dimetindene—Nortriptyline—CYP3A5—prostate cancer	0.00739	0.0261	CrCbGaD
Dimetindene—Brompheniramine—CYP2E1—prostate cancer	0.00705	0.0249	CrCbGaD
Dimetindene—Brompheniramine—CYP2C19—prostate cancer	0.00699	0.0247	CrCbGaD
Dimetindene—Alimemazine—CYP3A4—prostate cancer	0.00677	0.0239	CrCbGaD
Dimetindene—Imipramine—SLC22A1—prostate cancer	0.0064	0.0226	CrCbGaD
Dimetindene—Cyclobenzaprine—CYP3A4—prostate cancer	0.00623	0.022	CrCbGaD
Dimetindene—Disopyramide—CYP3A4—prostate cancer	0.00598	0.0211	CrCbGaD
Dimetindene—Clomipramine—CYP2C19—prostate cancer	0.00515	0.0182	CrCbGaD
Dimetindene—Amitriptyline—CYP3A5—prostate cancer	0.00513	0.0181	CrCbGaD
Dimetindene—Carbinoxamine—CYP3A4—prostate cancer	0.00513	0.0181	CrCbGaD
Dimetindene—Nortriptyline—CYP2E1—prostate cancer	0.00508	0.0179	CrCbGaD
Dimetindene—Nortriptyline—CYP2C19—prostate cancer	0.00503	0.0178	CrCbGaD
Dimetindene—Trimipramine—CYP2C19—prostate cancer	0.00474	0.0167	CrCbGaD
Dimetindene—Diphenhydramine—CYP2C19—prostate cancer	0.00465	0.0164	CrCbGaD
Dimetindene—Doxepin—CYP2C19—prostate cancer	0.00452	0.0159	CrCbGaD
Dimetindene—Orphenadrine—CYP2E1—prostate cancer	0.00444	0.0157	CrCbGaD
Dimetindene—Brompheniramine—CYP3A4—prostate cancer	0.00444	0.0157	CrCbGaD
Dimetindene—Chlorphenamine—CYP3A4—prostate cancer	0.00436	0.0154	CrCbGaD
Dimetindene—Promazine—CYP2C19—prostate cancer	0.00401	0.0142	CrCbGaD
Dimetindene—Imipramine—CYP2E1—prostate cancer	0.00355	0.0125	CrCbGaD
Dimetindene—Amitriptyline—CYP2E1—prostate cancer	0.00353	0.0124	CrCbGaD
Dimetindene—Imipramine—CYP2C19—prostate cancer	0.00351	0.0124	CrCbGaD
Dimetindene—Amitriptyline—CYP2C19—prostate cancer	0.00349	0.0123	CrCbGaD
Dimetindene—Clomipramine—CYP3A4—prostate cancer	0.00328	0.0116	CrCbGaD
Dimetindene—Nortriptyline—CYP3A4—prostate cancer	0.0032	0.0113	CrCbGaD
Dimetindene—Trimipramine—CYP3A4—prostate cancer	0.00301	0.0106	CrCbGaD
Dimetindene—Doxepin—CYP3A4—prostate cancer	0.00287	0.0101	CrCbGaD
Dimetindene—Orphenadrine—CYP3A4—prostate cancer	0.0028	0.00988	CrCbGaD
Dimetindene—Promazine—CYP3A4—prostate cancer	0.00255	0.00901	CrCbGaD
Dimetindene—Imipramine—CYP3A4—prostate cancer	0.00223	0.00789	CrCbGaD
Dimetindene—Amitriptyline—CYP3A4—prostate cancer	0.00222	0.00784	CrCbGaD
Dimetindene—HRH1—Signaling by GPCR—ANXA1—prostate cancer	0.000531	0.000741	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—PPP3CA—prostate cancer	0.00053	0.00074	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—CXCL12—prostate cancer	0.000526	0.000734	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—ANXA1—prostate cancer	0.000523	0.000729	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—PENK—prostate cancer	0.000518	0.000723	CbGpPWpGaD
Dimetindene—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—prostate cancer	0.000515	0.000719	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—PENK—prostate cancer	0.00051	0.000711	CbGpPWpGaD
Dimetindene—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—prostate cancer	0.000508	0.000709	CbGpPWpGaD
Dimetindene—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—prostate cancer	0.000507	0.000707	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—CALCA—prostate cancer	0.000497	0.000694	CbGpPWpGaD
Dimetindene—CHRM2—SIDS Susceptibility Pathways—IL6—prostate cancer	0.000497	0.000693	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—GHR—prostate cancer	0.000494	0.000689	CbGpPWpGaD
Dimetindene—HRH1—G alpha (q) signalling events—PIK3CA—prostate cancer	0.000493	0.000688	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—CALCA—prostate cancer	0.000489	0.000683	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—PRKCQ—prostate cancer	0.000488	0.000681	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—GHR—prostate cancer	0.000486	0.000678	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—CXCL12—prostate cancer	0.000486	0.000678	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—PRKCQ—prostate cancer	0.00048	0.00067	CbGpPWpGaD
Dimetindene—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—prostate cancer	0.00048	0.00067	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—CXCL12—prostate cancer	0.000478	0.000667	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—NRP1—prostate cancer	0.000474	0.000661	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—NRP1—prostate cancer	0.000466	0.00065	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—ADRB2—prostate cancer	0.000459	0.00064	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—ADRB2—prostate cancer	0.000452	0.00063	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—VAV3—prostate cancer	0.000448	0.000624	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—PRKCQ—prostate cancer	0.000443	0.000618	CbGpPWpGaD
Dimetindene—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—prostate cancer	0.000441	0.000616	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—VAV3—prostate cancer	0.00044	0.000614	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—VIP—prostate cancer	0.00044	0.000614	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—GNRH1—prostate cancer	0.00044	0.000614	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—PRKCQ—prostate cancer	0.000436	0.000609	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—ITPR1—prostate cancer	0.000434	0.000606	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—VIP—prostate cancer	0.000433	0.000605	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—GNRH1—prostate cancer	0.000433	0.000605	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—ITPR1—prostate cancer	0.000427	0.000596	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—LPAR1—prostate cancer	0.000426	0.000595	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—GRP—prostate cancer	0.000426	0.000595	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—PLCB2—prostate cancer	0.000422	0.000589	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—LRP2—prostate cancer	0.000422	0.000589	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—LPAR1—prostate cancer	0.00042	0.000585	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—GRP—prostate cancer	0.00042	0.000585	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—ADRB2—prostate cancer	0.000417	0.000582	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—PLCB2—prostate cancer	0.000415	0.00058	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—LRP2—prostate cancer	0.000415	0.00058	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—CX3CL1—prostate cancer	0.000414	0.000578	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—P4HB—prostate cancer	0.000414	0.000578	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—ADRB2—prostate cancer	0.00041	0.000572	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—P4HB—prostate cancer	0.000407	0.000568	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—CX3CL1—prostate cancer	0.000407	0.000568	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—VAV3—prostate cancer	0.000406	0.000567	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—HIST1H2BG—prostate cancer	0.000406	0.000567	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—GRB7—prostate cancer	0.000403	0.000562	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—PDE4D—prostate cancer	0.000403	0.000562	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—VAV3—prostate cancer	0.0004	0.000558	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—HIST1H2BG—prostate cancer	0.0004	0.000558	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—GRB7—prostate cancer	0.000396	0.000553	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—PDE4D—prostate cancer	0.000396	0.000553	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—ITPR1—prostate cancer	0.000394	0.00055	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—HIST1H4H—prostate cancer	0.000392	0.000548	CbGpPWpGaD
Dimetindene—HRH1—GPCR ligand binding—CXCL8—prostate cancer	0.000392	0.000547	CbGpPWpGaD
Dimetindene—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—prostate cancer	0.000391	0.000545	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—ITPR1—prostate cancer	0.000388	0.000541	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—HIST1H4H—prostate cancer	0.000386	0.000539	CbGpPWpGaD
Dimetindene—CHRM2—GPCR ligand binding—CXCL8—prostate cancer	0.000386	0.000538	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—GNG5—prostate cancer	0.000383	0.000534	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—GNG5—prostate cancer	0.000377	0.000526	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—PTHLH—prostate cancer	0.000334	0.000466	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—TGFBR1—prostate cancer	0.000334	0.000466	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—PTHLH—prostate cancer	0.000328	0.000458	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—TGFBR1—prostate cancer	0.000328	0.000458	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—AKR1C3—prostate cancer	0.000328	0.000458	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—PRKACB—prostate cancer	0.000327	0.000456	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—AKR1C3—prostate cancer	0.000323	0.000451	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—PRKACB—prostate cancer	0.000321	0.000448	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—THBS1—prostate cancer	0.000318	0.000444	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—PPP3CA—prostate cancer	0.000318	0.000444	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—ANXA1—prostate cancer	0.000314	0.000438	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—THBS1—prostate cancer	0.000313	0.000437	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—PPP3CA—prostate cancer	0.000313	0.000437	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—ANXA1—prostate cancer	0.000309	0.000431	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—PRKCZ—prostate cancer	0.000308	0.00043	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—PRKCZ—prostate cancer	0.000303	0.000423	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—PIK3CG—prostate cancer	0.000301	0.00042	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—FGFR4—prostate cancer	0.000297	0.000415	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—PARP1—prostate cancer	0.000297	0.000415	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—PIK3CG—prostate cancer	0.000296	0.000413	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—CALCA—prostate cancer	0.000294	0.00041	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—PARP1—prostate cancer	0.000293	0.000408	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—FGFR4—prostate cancer	0.000293	0.000408	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—CALCA—prostate cancer	0.000289	0.000403	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—CXCL12—prostate cancer	0.000287	0.0004	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—CXCL12—prostate cancer	0.000282	0.000394	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—PIK3CG—prostate cancer	0.000273	0.000381	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—CASP9—prostate cancer	0.00027	0.000377	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—PIK3CG—prostate cancer	0.000269	0.000375	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—CASP9—prostate cancer	0.000266	0.000371	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—PIK3CD—prostate cancer	0.000265	0.000369	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—PRKCQ—prostate cancer	0.000262	0.000365	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—NGFR—prostate cancer	0.000262	0.000365	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—PIK3CD—prostate cancer	0.00026	0.000363	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—MAP3K7—prostate cancer	0.000259	0.000361	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—NGFR—prostate cancer	0.000258	0.00036	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—PRKCQ—prostate cancer	0.000258	0.00036	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—MAP3K7—prostate cancer	0.000255	0.000355	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—FGF10—prostate cancer	0.000249	0.000347	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—ADRB2—prostate cancer	0.000246	0.000344	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—FGF10—prostate cancer	0.000245	0.000342	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—JAK2—prostate cancer	0.000243	0.000339	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—ADRB2—prostate cancer	0.000242	0.000338	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—MAP2K1—prostate cancer	0.000242	0.000338	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—PIK3CD—prostate cancer	0.00024	0.000335	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—VAV3—prostate cancer	0.00024	0.000335	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—JAK2—prostate cancer	0.000239	0.000333	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—MAP2K1—prostate cancer	0.000238	0.000332	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—TGFBR2—prostate cancer	0.000237	0.00033	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—PIK3CD—prostate cancer	0.000236	0.00033	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—VAV3—prostate cancer	0.000236	0.00033	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—ITPR1—prostate cancer	0.000233	0.000325	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—TGFBR2—prostate cancer	0.000233	0.000325	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—PIK3CB—prostate cancer	0.000231	0.000322	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—ITPR1—prostate cancer	0.000229	0.00032	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—PIK3CB—prostate cancer	0.000227	0.000317	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—IGF1R—prostate cancer	0.000223	0.000311	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—CXCL8—prostate cancer	0.000222	0.000309	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—JAK2—prostate cancer	0.000221	0.000308	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—IGF1R—prostate cancer	0.000219	0.000306	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—CXCL8—prostate cancer	0.000218	0.000304	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—JAK2—prostate cancer	0.000217	0.000303	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—LPL—prostate cancer	0.000213	0.000298	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—IL2—prostate cancer	0.000212	0.000296	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—PDGFRB—prostate cancer	0.000212	0.000295	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—LPL—prostate cancer	0.00021	0.000293	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—PIK3CB—prostate cancer	0.000209	0.000292	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—IL2—prostate cancer	0.000208	0.000291	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—PDGFRB—prostate cancer	0.000208	0.00029	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—ITGB3—prostate cancer	0.000206	0.000288	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—PIK3CB—prostate cancer	0.000206	0.000288	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—ITGB3—prostate cancer	0.000203	0.000283	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—CXCL8—prostate cancer	0.000201	0.000281	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—ERBB3—prostate cancer	0.0002	0.000279	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—FGFR2—prostate cancer	0.0002	0.000279	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—CXCL8—prostate cancer	0.000198	0.000276	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—ERBB3—prostate cancer	0.000197	0.000275	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—FGFR2—prostate cancer	0.000196	0.000274	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—IL2—prostate cancer	0.000192	0.000268	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—TERT—prostate cancer	0.000192	0.000267	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—IL2—prostate cancer	0.000189	0.000264	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—TERT—prostate cancer	0.000189	0.000263	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—HIF1A—prostate cancer	0.000183	0.000256	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—HIF1A—prostate cancer	0.00018	0.000252	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—LEP—prostate cancer	0.000179	0.00025	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—CAV1—prostate cancer	0.000177	0.000247	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—LEP—prostate cancer	0.000176	0.000246	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—KDR—prostate cancer	0.000175	0.000245	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—CAV1—prostate cancer	0.000174	0.000243	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—KDR—prostate cancer	0.000172	0.000241	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—ESR1—prostate cancer	0.000171	0.000238	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—ESR1—prostate cancer	0.000168	0.000235	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—BAD—prostate cancer	0.000167	0.000233	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—BAD—prostate cancer	0.000164	0.000229	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—PIK3CG—prostate cancer	0.000161	0.000225	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—APC—prostate cancer	0.000161	0.000225	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—IRS1—prostate cancer	0.00016	0.000223	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—EGF—prostate cancer	0.00016	0.000223	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—APC—prostate cancer	0.000159	0.000222	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—PIK3CG—prostate cancer	0.000159	0.000222	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—EGF—prostate cancer	0.000157	0.000219	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—IRS1—prostate cancer	0.000157	0.000219	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—GSK3B—prostate cancer	0.000155	0.000216	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—INS—prostate cancer	0.000153	0.000213	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—GSK3B—prostate cancer	0.000152	0.000213	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—INS—prostate cancer	0.00015	0.00021	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—CREBBP—prostate cancer	0.00015	0.000209	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—IGF1—prostate cancer	0.000148	0.000206	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—CREBBP—prostate cancer	0.000147	0.000206	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—EGFR—prostate cancer	0.000147	0.000205	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—IGF1—prostate cancer	0.000145	0.000203	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—EGFR—prostate cancer	0.000145	0.000202	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—MAP2K1—prostate cancer	0.000143	0.000199	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—PIK3CD—prostate cancer	0.000142	0.000198	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—PIK3CA—prostate cancer	0.000141	0.000196	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—MAP2K1—prostate cancer	0.000141	0.000196	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—SERPINE1—prostate cancer	0.00014	0.000196	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—PIK3CD—prostate cancer	0.00014	0.000195	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—KRAS—prostate cancer	0.000139	0.000194	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—PIK3CA—prostate cancer	0.000138	0.000193	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—SERPINE1—prostate cancer	0.000138	0.000193	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—KRAS—prostate cancer	0.000137	0.000191	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—FGF2—prostate cancer	0.000136	0.00019	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—NOS3—prostate cancer	0.000134	0.000187	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—FGF2—prostate cancer	0.000134	0.000187	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—NOS3—prostate cancer	0.000132	0.000184	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—JAK2—prostate cancer	0.00013	0.000182	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—JAK2—prostate cancer	0.000128	0.000179	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—PIK3CA—prostate cancer	0.000128	0.000178	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—MDM2—prostate cancer	0.000127	0.000177	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—PIK3CA—prostate cancer	0.000126	0.000175	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—ERBB2—prostate cancer	0.000125	0.000175	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—MDM2—prostate cancer	0.000125	0.000175	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—PIK3CB—prostate cancer	0.000124	0.000173	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—ERBB2—prostate cancer	0.000123	0.000172	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—PIK3CB—prostate cancer	0.000122	0.00017	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—CXCL8—prostate cancer	0.000119	0.000166	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—CXCL8—prostate cancer	0.000117	0.000163	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—CDKN1B—prostate cancer	0.000116	0.000162	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—AKT1—prostate cancer	0.000115	0.00016	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—CDKN1B—prostate cancer	0.000114	0.000159	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—CASP3—prostate cancer	0.000114	0.000159	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—IL2—prostate cancer	0.000114	0.000159	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—IL6—prostate cancer	0.000113	0.000158	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—AKT1—prostate cancer	0.000113	0.000158	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—CASP3—prostate cancer	0.000112	0.000156	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—IL2—prostate cancer	0.000112	0.000156	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—IL6—prostate cancer	0.000111	0.000155	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—CCND1—prostate cancer	0.000111	0.000155	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—CTNNB1—prostate cancer	0.00011	0.000153	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—CCND1—prostate cancer	0.000109	0.000152	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—CTNNB1—prostate cancer	0.000108	0.000151	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—MMP9—prostate cancer	0.000108	0.00015	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—CDKN1A—prostate cancer	0.000107	0.00015	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—PTEN—prostate cancer	0.000107	0.000149	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—MMP9—prostate cancer	0.000106	0.000148	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—CDKN1A—prostate cancer	0.000105	0.000147	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—PTEN—prostate cancer	0.000105	0.000147	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—AKT1—prostate cancer	0.000104	0.000146	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—AKT1—prostate cancer	0.000103	0.000143	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—EP300—prostate cancer	0.000102	0.000142	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—EP300—prostate cancer	0.0001	0.00014	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—SRC—prostate cancer	9.91e-05	0.000138	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—SRC—prostate cancer	9.76e-05	0.000136	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—VEGFA—prostate cancer	9.66e-05	0.000135	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—STAT3—prostate cancer	9.56e-05	0.000133	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—VEGFA—prostate cancer	9.5e-05	0.000133	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—STAT3—prostate cancer	9.41e-05	0.000131	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—MYC—prostate cancer	8.88e-05	0.000124	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—TGFB1—prostate cancer	8.86e-05	0.000124	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—MYC—prostate cancer	8.74e-05	0.000122	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—TGFB1—prostate cancer	8.72e-05	0.000122	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—EGFR—prostate cancer	8.69e-05	0.000121	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—EGFR—prostate cancer	8.55e-05	0.000119	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—KRAS—prostate cancer	8.21e-05	0.000115	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—KRAS—prostate cancer	8.08e-05	0.000113	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—PIK3CA—prostate cancer	7.54e-05	0.000105	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—PIK3CA—prostate cancer	7.42e-05	0.000104	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—TP53—prostate cancer	7.3e-05	0.000102	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—TP53—prostate cancer	7.18e-05	0.0001	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—IL6—prostate cancer	6.68e-05	9.32e-05	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—IL6—prostate cancer	6.57e-05	9.17e-05	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—AKT1—prostate cancer	6.16e-05	8.6e-05	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—AKT1—prostate cancer	6.06e-05	8.46e-05	CbGpPWpGaD
